Health Risks of Travelers With Medical Conditions—A Retrospective AnalysisWIETEN, Rosanne W; LEENSTRA, Tjalling; GOORHUIS, Abraham et al.Journal of travel medicine. 2012, Vol 19, Num 2, pp 104-110, issn 1195-1982, 7 p.Article

Building Capacity for the Assessment of HIV Drug Resistance: Experiences From the PharmAccess African Studies to Evaluate Resistance NetworkHAMERS, Raph L; STRAATSMA, Elske; WELLINGTON, Maureen et al.Clinical infectious diseases. 2012, Vol 54, issn 1058-4838, S261-S265, SUP4Article

Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance—HIV drug resistance in sub-Saharan Africa and the Asia-PacificHAMERS, Raph L; OYOMOPITO, Rebecca; ABDALLAH, Saade et al.International journal of epidemiology. 2012, Vol 41, Num 1, pp 43-54, issn 0300-5771, 12 p.Article

Dengue in travellers: applicability of the 1975―1997 and the 2009 WHO classification system of dengue feverWIETEN, Rosanne W; VLIETSTRA, Wytze; GROBUSCH, Martin P et al.TM & IH. Tropical medicine & international health. 2012, Vol 17, Num 8, pp 1023-1030, issn 1360-2276, 8 p.Article

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort studyHAMERS, Raph L; SCHUURMAN, Rob; OSIBOGUN, Akin et al.Lancet. Infectious diseases (print). 2012, Vol 12, Num 4, pp 307-317, issn 1473-3099, 11 p.Article

Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in AfricaSIGALOFF, Kim C. E; HAMERS, Raph L; STEVENS, Wendy S et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 1, pp 23-31, issn 1525-4135, 9 p.Article